Measurement of human growth hormone by immunoassays: Current status, unsolved problems and clinical consequences

Gemzell, 1955, A method for demonstrating growth hormone activity in human plasma, J. Clin. Endocrinol. Metab., 15, 537, 10.1210/jcem-15-5-537 Segaloff, 1955, The growth hormone content of human plasma, Endocrinology, 57, 527, 10.1210/endo-57-5-527 Dattani, 1993, Enhancement of growth hormone bioactivity by zinc in the eluted stain assay system, Endocrinology, 133, 2803, 10.1210/en.133.6.2803 Lesniak, 1974, Binding of 125I-human growth hormone to specific receptors in human cultured lymphocytes. Characterization of the interaction and a sensitive radioreceptor assay, J. Biol. Chem., 249, 1661, 10.1016/S0021-9258(19)42840-8 Yalow, 1959, Assay of plasma insulin in human subjects by immunological methods, Nature, 184, 1648, 10.1038/1841648b0 Ehrlich, 1961, Immunoassay of growth hormone in human serum, Lancet, 2, 230, 10.1016/S0140-6736(61)90355-5 Schalch, 1964, A Sensitive double antibody immunoassay for human growth hormone in plasma, Nature, 203, 1141, 10.1038/2031141a0 Morris, 1964, Rapid quantitative immunologic assay for human growth hormone, J. Clin. Endocrinol. Metab., 24, 417, 10.1210/jcem-24-5-417 Orskov, 1968, Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone, Nature, 219, 193, 10.1038/219193b0 van Weemen, 2005, The rise of EIA/ELISA, Clin. Chem., 51, 2226, 10.1373/clinchem.2005.059626 Wu, 2006, A selected history and future of immunoassay development and applications in clinical chemistry, Clin. Chim. Acta, 369, 119, 10.1016/j.cca.2006.02.045 Chapman, 1994, Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women, J. Clin. Endocrinol. Metab., 78, 1312, 10.1210/jc.78.6.1312 Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the growth hormone research society workshop on adult growth hormone deficiency, J. Clin. Endocrinol. Metab. 83 (1998) 379–381. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH research society, J. Clin. Endocrinol. Metab. 85 (2000) 3990–3993. Giustina, 2000, Criteria for cure of acromegaly: a consensus statement, J. Clin. Endocrinol. Metab., 85, 526, 10.1210/jc.85.2.526 Melmed, 2005, Consensus statement: medical management of acromegaly, Eur. J. Endocrinol., 153, 737, 10.1530/eje.1.02036 Hauffa, 2004, Central reassessment of GH concentrations measured at local treatment centers in children with impaired growth: consequences for patient management, Eur. J. Endocrinol., 150, 291, 10.1530/eje.0.1500291 Popii, 2004, Laboratory measurement of growth hormone, Clin. Chim. Acta, 350, 1, 10.1016/j.cccn.2004.06.007 Strasburger, 2008, How robust are laboratory measures of growth hormone status?, Horm. Res., 64, 1 Bidlingmaier, 1991, Our experience with quality control in current growth hormone assays, Horm. Res., 36, 1, 10.1159/000182178 Seth, 1999, Serum growth hormone measurements in clinical practice: an audit of performance from the UK National External Quality Assessment scheme, Horm. Res., 51, 13, 10.1159/000053130 Morsky, 2005, Problematic determination of serum growth hormone: experience from external quality assurance surveys 1998–2003, Scand. J. Clin. Lab. Invest., 65, 377, 10.1080/00365510510025791 Tanaka, 2005, A nationwide attempt to standardize growth hormone assays, Horm. Res., 64 Celniker, 1989, Variability in the quantitation of circulating growth hormone using commercial immunoassays, J. Clin. Endocrinol. Metab., 68, 469, 10.1210/jcem-68-2-469 Granada, 1990, Assay-dependent results of immunoassayable spontaneous 24-hour growth hormone secretion in short children, Acta Paediatr. Scand., 63, 10.1111/j.1651-2227.1990.tb11675.x Markkanen, 2006, Effect of sex and assay method on serum concentrations of growth hormone in patients with acromegaly and in healthy controls, Clin. Chem., 52, 468, 10.1373/clinchem.2005.060236 Derr, 2006, Pre-analytic considerations for the proper assessment of hormones of the hypothalamic–pituitary axis in epidemiological research, Eur. J. Epidemiol., 21, 217, 10.1007/s10654-006-0011-0 Evans, 2001, Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones, Clin. Biochem., 34, 107, 10.1016/S0009-9120(01)00196-5 Baumann, 1991, Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins, Endocr. Rev., 12, 424, 10.1210/edrv-12-4-424 Baumann, 1999, Growth hormone heterogeneity in human pituitary and plasma, Horm. Res., 51, 2, 10.1159/000053128 Baumann, 1986, The metabolic clearance, distribution, and degradation of dimeric and monomeric growth hormone (GH): implications for the pattern of circulating GH forms, Endocrinology, 119, 1497, 10.1210/endo-119-4-1497 Sturgeon, 2009, Differences in recognition of the 1st WHO international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin, Clin. Chem., 55, 1484, 10.1373/clinchem.2009.124578 Sturgeon, 2007, Standardization of FSH, LH and hCG – current position and future prospects, Mol. Cell. Endocrinol., 260–262, 301, 10.1016/j.mce.2006.09.004 Chatelain, 1990, Assay of growth hormone levels in human plasma using commercial kits: analysis of some factors influencing the results, Acta Paediatr. Scand., 56, 10.1111/j.1651-2227.1990.tb11673.x Reiter, 1988, Variable estimates of serum growth hormone concentrations by different radioassay systems, J. Clin. Endocrinol. Metab., 66, 68, 10.1210/jcem-66-1-68 Tsushima, 1999, Serum concentration of 20K human growth hormone (20K hGH) measured by a specific enzyme-linked immunosorbent assay. Study group of 20K hGH, J. Clin. Endocrinol. Metab., 84, 317, 10.1210/jc.84.1.317 Leung, 2002, Physiological and pharmacological regulation of 20-kDa growth hormone, Am. J. Physiol. Endocrinol. Metab., 283, E836, 10.1152/ajpendo.00122.2002 Wu, 1999, Detection of doping with human growth hormone, Lancet, 353, 895, 10.1016/S0140-6736(99)00775-8 Boguszewski, 2000, Growth hormone isoforms in newborns and postpartum women, Eur. J. Endocrinol., 142, 353, 10.1530/eje.0.1420353 Bidlingmaier, 2009, High-sensitivity chemiluminescence immunoassays for detection of growth hormone doping in sports, Clin. Chem., 55, 445, 10.1373/clinchem.2008.112458 Trainer, 2000, Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant, N. Engl. J. Med., 342, 1171, 10.1056/NEJM200004203421604 Paisley, 2007, Pegvisomant interference in GH assays results in underestimation of GH levels, Eur. J. Endocrinol., 156, 315, 10.1530/eje.1.02341 Thorner, 1999, Growth hormone (GH) receptor blockade with a PEG-modified GH (B2036-PEG) lowers serum insulin-like growth factor-I but does not acutely stimulate serum GH, J. Clin. Endocrinol. Metab., 84, 2098, 10.1210/jc.84.6.2098 Veldhuis, 2001, J. Clin. Endocrinol. Metab., 86, 3304, 10.1210/jc.86.7.3304 Colao, 2006, Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance, Eur. J. Endocrinol., 154, 467, 10.1530/eje.1.02112 Brian, 2007, Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects, J. Clin. Endocrinol. Metab., 92, 3374, 10.1210/jc.2007-0997 Pokrajac, 2007, Variation in GH and IGF-I assays limits the applicability of international consensus criteria to local practice, Clin. Endocrinol., 67, 65, 10.1111/j.1365-2265.2007.02836.x Trainer, 2006, Consensus statement on the standardisation of GH assays, Eur. J. Endocrinol., 155, 1, 10.1530/eje.1.02186 Baumann, 2001, Growth hormone binding protein 2001, J. Pediatr. Endocrinol. Metab., 14, 355, 10.1515/JPEM.2001.14.4.355 Amit, 2000, Clinical review 112: does serum growth hormone (GH) binding protein reflect human GH receptor function?, J. Clin. Endocrinol. Metab., 85, 927, 10.1210/jc.85.3.927 Jan, 1991, Effects of growth hormone-binding proteins on serum growth hormone measurements, J. Clin. Endocrinol. Metab., 72, 387, 10.1210/jcem-72-2-387 Ebdrup, 1999, Variety in growth hormone determinations due to use of different immunoassays and to the interference of growth hormone-binding protein, Horm. Res., 51, 20, 10.1159/000053131 Jansson, 1997, Growth hormone (GH) assays: influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein, Clin. Chem., 43, 950, 10.1093/clinchem/43.6.950 Hansen, 2002, Impact of GHBP interference on estimates of GH and GH pharmacokinetics, Clin. Endocrinol., 57, 779, 10.1046/j.1365-2265.2002.01668.x Freda, 1998, Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly, J. Clin. Endocrinol. Metab., 83, 3808, 10.1210/jc.83.11.3808 Freda, 2003, Pitfalls in the biochemical assessment of acromegaly, Pituitary, 6, 135, 10.1023/B:PITU.0000011174.79946.10 Costa, 2002, Assessment of disease activity in treated acromegalic patients using a sensitive GH Assay: should we achieve strict normal GH levels for a biochemical cure?, J. Clin. Endocrinol. Metab., 87, 3142, 10.1210/jc.87.7.3142 Freda, 2003, Current concepts in the biochemical assessment of the patient with acromegaly, Growth Horm. IGF Res., 13, 171, 10.1016/S1096-6374(03)00029-7 Hattori, 1990, Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegaly, J. Clin. Endocrinol. Metab., 70, 771, 10.1210/jcem-70-3-771 Arafat, 2008, Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index, J. Clin. Endocrinol. Metab., 93, 1254, 10.1210/jc.2007-2084 De Marinis, 2002, Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients, Metabolism, 51, 616, 10.1053/meta.2002.32017 Mercado, 2004, Clinical-biochemical correlations in acromegaly at diagnosis and the real prevalence of biochemically discordant disease, Horm. Res., 62, 293, 10.1159/000082032 Feelders, 2005, Postoperative evaluation of patients with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels, J. Clin. Endocrinol. Metab., 90, 6480, 10.1210/jc.2005-0901 Serri, 2004, Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly, J. Clin. Endocrinol. Metab., 89, 658, 10.1210/jc.2003-030915 Dimaraki, 2002, Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up, J. Clin. Endocrinol. Metab., 87, 3537, 10.1210/jc.87.8.3537 Rakover, 2000, Comparison between four immunoassays for growth hormone (GH) measurement as guides to clinical decisions following GH provocative tests, J. Pediatr. Endocrinol. Metab., 13, 637, 10.1515/JPEM.2000.13.6.637 Amed, 2008, Variation in growth hormone immunoassays in clinical practice in Canada, Horm. Res., 69, 290, 10.1159/000114860 Juul, 2002, European audit of current practice in diagnosis and treatment of childhood growth hormone deficiency, Horm. Res., 58, 233, 10.1159/000066265 Wieringa, 2004, Growth hormone assay standardization: a biased view?, Clin. Endocrinol., 60, 538, 10.1046/j.1365-2265.2004.01982.x Trainer, 2006, Consensus statement on the standardisation of GH assays, Eur. J. Endocrinol., 155, 1, 10.1530/eje.1.02186 Sheppard, 2007, Growth hormone assay standardization: an important clinical advance, Clin. Endocrinol., 66, 157, 10.1111/j.1365-2265.2007.02703.x Bidlingmaier, 2007, Growth hormone assays: current methodologies and their limitations, Pituitary, 10, 115, 10.1007/s11102-007-0030-1 Bidlingmaier, 2007, What endocrinologists should know about growth hormone measurements, Endocrinol. Metab. Clin. North Am., 36, 101, 10.1016/j.ecl.2006.11.004 Stenman, 2001, Immunoassay standardization: is it possible, who is responsible, who is capable?, Clin. Chem., 47, 815, 10.1093/clinchem/47.5.815 Hayakawa, 2004, Metabolic effects of 20-kilodalton human growth hormone (20K-hGH) for adults with growth hormone deficiency: results of an exploratory uncontrolled multicenter clinical trial of 20K-hGH, J. Clin. Endocrinol. Metab., 89, 1562, 10.1210/jc.2003-030716 Ross, 2008, Reporting growth hormone assay results in terms of one consensus recombinant standard preparation offers less than optimal reduction of between-method variation, Clin. Chem. Lab. Med., 46, 1334, 10.1515/CCLM.2008.261 Lequin, 2002, Standardization: comparability and traceability of laboratory results, Clin. Chem., 48, 391, 10.1093/clinchem/48.2.391 Miller, 2006, Why commutability matters, Clin. Chem., 52, 553, 10.1373/clinchem.2005.063511 Bidlingmaier, 2008, Problems with GH assays and strategies toward standardization, Eur. J. Endocrinol., 159, S41, 10.1530/EJE-08-0284 Molitch, 2006, Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline, J. Clin. Endocrinol. Metab., 91, 1621, 10.1210/jc.2005-2227 Iwahara, 2007, Comparison of access ultrasensitive human growth hormone assay to monoclonal antibody-based immunoradiometric assay, Clin. Chim. Acta, 376, 248, 10.1016/j.cca.2006.09.018